Accolade (Accolade) GF Value : $14.13 (As of May. 14, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Accolade GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-14), Accolade's share price is $7.36. Accolade's GF Value is $14.13. Therefore, Accolade's Price-to-GF-Value for today is 0.52.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Accolade is Possible Value Trap, Think Twice.

Accolade (NAS:ACCD) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Accolade's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	7.36	/	14.13
	=	0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accolade GF Value Related Terms

Thank you for viewing the detailed overview of Accolade's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Accolade (Accolade) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

4NE1:Germany

Address

1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101

Website

https://www.accolade.com

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Executives

Richard Eskew	officer: EVP General Counsel	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Stephen H. Barnes	officer: Chief Financial Officer	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh	director, officer: Chief Executive Officer	6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh	officer: President	1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Mchugh Colin	officer: Chief Accounting Officer	C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Michael W Hilton	officer: Chief Product Officer	6222 185TH AVE, REDMOND WA 98052
Peter S Klein	director	C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent	director	7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors	director	C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore	director	1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan	director	2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel	director	BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky	director	C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff	director	SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist	director	600 MONTGOMERY STREET, SAN FRANCISCO CA 94111